scholarly journals Myeloperoxidase-Generated Oxidants Modulate Left Ventricular Remodeling but Not Infarct Size After Myocardial Infarction

Circulation ◽  
2005 ◽  
Vol 112 (18) ◽  
pp. 2812-2820 ◽  
Author(s):  
Nikolay Vasilyev ◽  
Timothy Williams ◽  
Marie-Luise Brennan ◽  
Samuel Unzek ◽  
Xiaorong Zhou ◽  
...  
2019 ◽  
Vol 125 (2) ◽  
pp. 245-258 ◽  
Author(s):  
Giampaolo Niccoli ◽  
Rocco A. Montone ◽  
Borja Ibanez ◽  
Holger Thiele ◽  
Filippo Crea ◽  
...  

Primary percutaneous coronary intervention is nowadays the preferred reperfusion strategy for patients with acute ST-segment–elevation myocardial infarction, aiming at restoring epicardial infarct-related artery patency and achieving microvascular reperfusion as early as possible, thus limiting the extent of irreversibly injured myocardium. Yet, in a sizeable proportion of patients, primary percutaneous coronary intervention does not achieve effective myocardial reperfusion due to the occurrence of coronary microvascular obstruction (MVO). The amount of infarcted myocardium, the so-called infarct size, has long been known to be an independent predictor for major adverse cardiovascular events and adverse left ventricular remodeling after myocardial infarction. Previous cardioprotection studies were mainly aimed at protecting cardiomyocytes and reducing infarct size. However, several clinical and preclinical studies have reported that the presence and extent of MVO represent another important independent predictor of adverse left ventricular remodeling, and recent evidences support the notion that MVO may be more predictive of major adverse cardiovascular events than infarct size itself. Although timely and complete reperfusion is the most effective way of limiting myocardial injury and subsequent ventricular remodeling, the translation of effective therapeutic strategies into improved clinical outcomes has been largely disappointing. Of importance, despite the presence of a large number of studies focused on infarct size, only few cardioprotection studies addressed MVO as a therapeutic target. In this review, we provide a detailed summary of MVO including underlying causes, diagnostic techniques, and current therapeutic approaches. Furthermore, we discuss the hypothesis that simultaneously addressing infarct size and MVO may help to translate cardioprotective strategies into improved clinical outcome following ST-segment–elevation myocardial infarction.


2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Zequan Yang ◽  
Yikui Tian ◽  
Stuart S. Berr ◽  
Brent A. French

Background. We hypothesized that daily administration of a potent antioxidant (α-lipoic acid: ALA) would protect the heart against both acute myocardial infarction (AMI) and left ventricular remodeling (LVR) post-AMI. Methods and Results. Two separate studies were conducted. In the AMI study, C57Bl/6 mice were fed ALA daily for 7 d prior to a 45-minute occlusion of the left coronary artery (LCA). Mean infarct size in control mice (fed water) was 60 ± 2%. Mean infarct size in ALA-treated mice was 42 ± 3% in the 15 mg/kg·d group and 39 ± 3% in the 75 mg/kg·d group (both P<0.05 vs. control). In the LVR study, AMI increased LV end-systolic volume (LVESV) and reduced LV ejection fraction (LVEF) to a similar extent in both groups when assessed by cardiac MRI 1 day after a 2-hour LCA occlusion. Treatment with ALA (75 mg/kg·d) or H2O was initiated 1 day post-AMI and continued until study’s end. Both LVESV and LVEF in ALA-treated mice were significantly improved over control when assessed 28 or 56 days post-AMI. Furthermore, the survival rate in ALA-treated mice was 63% better than in control mice by 56 days post-AMI. Conclusions. Daily oral ingestion of ALA not only protects mice against AMI but also attenuates LVR and preserves contractile function in the months that follow.


2009 ◽  
Vol 104 (9) ◽  
pp. 1179-1183 ◽  
Author(s):  
Stein Ørn ◽  
Unni M. Breland ◽  
Tom Eirik Mollnes ◽  
Cord Manhenke ◽  
Kenneth Dickstein ◽  
...  

1995 ◽  
Vol 25 (3) ◽  
pp. 567-573 ◽  
Author(s):  
Panithaya Chareonthaitawee ◽  
Timothy F. Christian ◽  
Ken Hirose ◽  
Raymond J. Gibbons ◽  
John A. Rumberger

Sign in / Sign up

Export Citation Format

Share Document